ARCT vs UTHR · rev $5.0M vs P/E 20, rev $1.56B
Arcturus Therapeutics Holdings Inc (ARCT) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Arcturus Therapeutics Holdings Inc (ARCT) is a biotechnology company listed on US.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported ARCT revenue for 2026-06-30 was $5.0M. Net income was -$50.7M. ARCT currently screens at market cap $369.4M.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
ARCT currently screens at market cap $369.4M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the ARCT and UTHR stock pages for the full models.
Not investment advice.